Renaissance Technologies’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-304,480
Closed -$73.3M 3614
2025
Q4
$73.3M Buy
304,480
+246,480
+425% +$63M 0.11% 206
2025
Q3
$15.9M Sell
58,000
-45,000
-44% -$12.3M 0.02% 847
2025
Q2
$26.6M Buy
103,000
+49,000
+91% +$11.7M 0.04% 595
2025
Q1
$12.1M Sell
54,000
-193,700
-78% -$45.2M 0.02% 907
2024
Q4
$56.6M Buy
247,700
+163,700
+195% +$39.4M 0.08% 281
2024
Q3
$20.5M Sell
84,000
-135,600
-62% -$30.3M 0.03% 651
2024
Q2
$42M Buy
+219,600
New +$44.6M 0.07% 341
2023
Q4
Sell
-405,200
Closed -$59.9M 4065
2023
Q3
$59.9M Buy
405,200
+14,500
+4% +$2.62M 0.1% 214
2023
Q2
$85.4M Buy
390,700
+261,500
+202% +$58.3M 0.12% 186
2023
Q1
$28.3M Sell
129,200
-95,696
-43% -$20.8M 0.04% 556
2022
Q4
$46.8M Buy
224,896
+178,340
+383% +$39.2M 0.06% 359
2022
Q3
$10.1M Buy
46,556
+3,908
+9% +$889K 0.01% 1023
2022
Q2
$8.96M Buy
42,648
+21,913
+106% +$4.67M 0.01% 1166
2022
Q1
$5.03M Sell
20,735
-16,503
-44% -$3.99M 0.01% 1589
2021
Q4
$9.69M Buy
37,238
+35,266
+1,788% +$9.15M 0.01% 1089
2021
Q3
$531K Buy
+1,972
New +$539K ﹤0.01% 2866
2021
Q2
Sell
-6,887
Closed -$1.32M 3727
2021
Q1
$1.32M Buy
6,887
+3,680
+115% +$738K ﹤0.01% 2477
2020
Q4
$672K Sell
3,207
-9,893
-76% -$1.97M ﹤0.01% 2693
2020
Q3
$2.25M Buy
+13,100
New +$2.42M ﹤0.01% 2062
2020
Q1
Sell
-128,546
Closed -$19.9M 3733
2019
Q4
$19.9M Buy
128,546
+121,446
+1,711% +$17.5M 0.02% 1008
2019
Q3
$959K Sell
7,100
-22,269
-76% -$2.92M ﹤0.01% 2620
2019
Q2
$3.54M Buy
+29,369
New +$3.25M ﹤0.01% 2020
2019
Q1
Sell
-333,424
Closed -$37.9M 3654
2018
Q4
$37.9M Sell
333,424
-414,476
-55% -$44.4M 0.04% 544
2018
Q3
$86.3M Buy
747,900
+447,649
+149% +$49M 0.09% 264
2018
Q2
$31.1M Buy
300,251
+118,928
+66% +$12M 0.03% 665
2018
Q1
$17.7M Sell
181,323
-100,911
-36% -$9.54M 0.02% 1003
2017
Q4
$24M Buy
282,234
+235,734
+507% +$19.5M 0.03% 832
2017
Q3
$3.58M Buy
+46,500
New +$3.56M ﹤0.01% 1961
2017
Q2
Sell
-32,700
Closed -$2.35M 3335
2017
Q1
$2.35M Sell
32,700
-352,600
-92% -$24.4M ﹤0.01% 2155
2016
Q4
$23.9M Sell
385,300
-1,036,300
-73% -$63.5M 0.04% 669
2016
Q3
$92.1M Buy
1,421,600
+632,900
+80% +$42.1M 0.16% 113
2016
Q2
$49.9M Sell
788,700
-494,400
-39% -$29.1M 0.09% 261
2016
Q1
$74.2M Buy
1,283,100
+17,000
+1% +$962K 0.14% 135
2015
Q4
$68M Sell
1,266,100
-94,900
-7% -$5.35M 0.15% 129
2015
Q3
$69.4M Buy
+1,361,000
New +$73.3M 0.17% 105
2015
Q2
Sell
-83,100
Closed -$5.96M 3346
2015
Q1
$5.96M Sell
83,100
-369,800
-82% -$24M 0.01% 1243
2014
Q4
$25.4M Buy
+452,900
New +$23.6M 0.06% 394
2014
Q2
Sell
-14,800
Closed -$661K 2935
2014
Q1
$661K Sell
14,800
-605,000
-98% -$27.2M ﹤0.01% 2243
2013
Q4
$29.2M Sell
619,800
-72,300
-10% -$3.66M 0.07% 340
2013
Q3
$36.6M Buy
+692,100
New +$33.6M 0.09% 261

Other funds holding RMD

Renaissance Technologies's RMD Position: Q1 2026 in Review

Renaissance Technologies sold out of ResMed (RMD) in Q1 2026, closing a stake of 304,480 shares — an estimated $73.3M sold.

Renaissance Technologies first reported a position in RMD in Q3 2013 and held it in 40 quarters. The position peaked at $92.1M in Q3 2016. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Renaissance Technologies reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Renaissance Technologies sold 304,480 ResMed shares in Q1 2026, an estimated $73.3M.
  • Renaissance Technologies first reported a position in ResMed in Q3 2013 and held it in 40 quarters.
  • Renaissance Technologies's ResMed position peaked at $92.1M in Q3 2016.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.